Veterinary Medicines

Biocan DHPPi+LR lyofilizát a tekutá zložka na injekčnú suspenziu

Authorised
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain MSLB 1010, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1008, Inactivated
  • Leptospira kirschneri, serogroup Grippotyphosa, serovar Grippotyphosa, strain MSLB 1009, Inactivated
  • Rabies virus, Inactivated
  • Canine parainfluenza virus, Live
  • Canine parvovirus, Live
  • Canine adenovirus 2, Live
  • Canine distemper virus, Live
Download as PDF

Product identification

Medicine name:
Biocan DHPPi+LR lyofilizát a tekutá zložka na injekčnú suspenziu
Active substance:
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain MSLB 1010, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1008, Inactivated
  • Leptospira kirschneri, serogroup Grippotyphosa, serovar Grippotyphosa, strain MSLB 1009, Inactivated
  • Rabies virus, Inactivated
  • Canine parainfluenza virus, Live
  • Canine parvovirus, Live
  • Canine adenovirus 2, Live
  • Canine distemper virus, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain MSLB 1010, Inactivated
    10.00
    million organisms
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1008, Inactivated
    10.00
    million organisms
    /
    1.00
    millilitre(s)
  • Leptospira kirschneri, serogroup Grippotyphosa, serovar Grippotyphosa, strain MSLB 1009, Inactivated
    10.00
    million organisms
    /
    1.00
    millilitre(s)
  • Rabies virus, Inactivated
    2.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Canine parainfluenza virus, Live
    3.00
    log10 tissue culture infective dose 50
    /
    1.00
    millilitre(s)
  • Canine parvovirus, Live
    4.50
    log10 tissue culture infective dose 50
    /
    1.00
    millilitre(s)
  • Canine adenovirus 2, Live
    3.50
    log10 tissue culture infective dose 50
    /
    1.00
    millilitre(s)
  • Canine distemper virus, Live
    3.00
    log10 tissue culture infective dose 50
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
      • Not applicable
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AJ06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta SK s.r.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/014/08-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 28/12/2021
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."